IRLAB Therapeutics AB (publ) Cash Flow Quality Index
IRLAB Therapeutics AB (publ) cash flow quality index. IRLAB Therapeutics AB (publ) (IRLAB-A) has a Cash Flow Quality Index of 1.67x as of September 2021. Operating cash flow of Skr202.83 Million exceeds net income of Skr121.67 Million, indicating high earnings quality where cash backs reported profits. See IRLAB-A financial flexibility score to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of IRLAB Therapeutics AB (publ) (2021–2021)
Cash flow quality index of IRLAB Therapeutics AB (publ) from 2021 to 2021. Historical Cash Flow Quality Index for IRLAB Therapeutics AB (publ) across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore IRLAB Therapeutics AB (publ) (IRLAB-A) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
IRLAB Therapeutics AB (publ) Cash Flow Quality Index by Year (2021–2021)
IRLAB Therapeutics AB (publ) cash flow quality index by year from 2021 to 2021. Year-by-year earnings quality comparison for IRLAB Therapeutics AB (publ). For the full cash flow conversion analysis, see IRLAB Therapeutics AB (publ) operating cash flow efficiency.
| Year | Quality Index | Operating CF (SEK) | Net Income | YoY Change |
|---|---|---|---|---|
| 2021 | 2.45x | Skr128.64 Million | Skr52.58 Million | — |